Indian Immunologicals offers a wide range of animal and human vaccines, hormones, and nutraceuticals for human health, as well as contract manufacturing services for leading pharmaceutical and vaccine companies. Indian Immunologicals has developed the world's first tissue culture rabies vaccine and the first vaccine for Porcine cysticercosis. They export their products to over 50 countries and have manufacturing facilities in Hyderabad. The company is set to launch vaccines for Hepatitis A and Measles and Rubella in 2023 and has also expanded its operations in New Zealand through its subsidiary, Pristine Biologicals.
Legal Address
Indian Immunologicals Limited, Road No. 44, Jubilee Hills
Hyderabad; Telangana;
Postal Code: 500033
Contact Details: Purchase the Indian Immunologicals Limited report to view the information.
Website: http://www.indimmune.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service